Aim Rule 26
The following information is disclosed in accordance with Rule 26 of the AIM Rules (February 2007):
Description of the business
Please click on the link below for a description of the business.
Link: Description of the business
Last updated: 26 January 2012
The names of the directors and biographical details
Please click on the link below for the names of the directors and brief biographical details of each.
Link: The names of the directors and biographical details
Last updated: 22 March 2012
Directors' responsibilities
Please click on the link below for a description of Directors' responsibilities.
Link: Directors' responsibilities
Last updated: 26 January 2012
Board committees
Please click on the link below for information on the Audit and Remuneration Committees together with the membership of those committees.
Link: Remuneration Committee
Link: Audit Committee
Last updated: 26 January 2012
Country of incorporation and main country of operation
Alliance Pharma plc is incorporated in England (Registration Number 04241478). Its main country of operation is the United Kingdom.
Last updated: 26 January 2012
Current constitutional documents
Please click on the link below for the Memorandum and the Articles of Association.
Link: Memorandum of Association (264 Kb PDF)
Link: Articles of Association (310 Kb PDF)
Last updated: 26 January 2012
Details of exchanges and trading platforms
The Company’s ordinary shares are listed on AIM (EPIC code: APH) and not on any other exchanges or trading platforms.
The Company’s Convertible Unsecured Subordinated Loan Stock 2013 are also traded on AIM (EPIC code: APHA).
Last updated: 26 January 2012
Number of securities in issue
The number of ordinary shares in issue is 240,647,045. The Company does not hold any ordinary shares in Treasury. Insofar as the Company is aware, the percentage of securities that is not in public hands as defined by Aim Rule 26 is 72.48%.
Please click on the link below for a list of Directors & Major Shareholders and the percentage of their holdings.
Link: Directors & Major Shareholders
Last updated: 08 May 2012
Details of any restrictions on the transfer of securities
There are no restrictions on the transfer of securities.
Last updated: 26 January 2012
Financial information
Please click on the link below for access to the Company's annual and interim reports.
Link: Financial information
Last updated: 22 March 2012
Company announcements
Please click on the link below to access notifications made by the Company in the past 12 months.
Link: Company announcements
Last updated: N/A
Admission document and circulars
There have been no circulars or similar publications within the past 12 months.
Please click on the link below to access the Company's Admission Document dated 28th November 2003.
Link: Admission Document
Last updated: 26 January 2012
Advisers
Please click on the link below for details of the Company's Nominated Adviser and other key advisers.
Link: Advisers
Last updated: 26 January 2012